Mesenchymal stem cells overexpressing angiotensin-converting enzyme 2 rescue lipopolysaccharide-induced lung injury

Cell Transplantation

Volumn 24, Issue 9, 2015, Pages 1699-1715

  He, Hongli ^a   Liu, Ling ^a   Chen, Qihong ^a   Liu, Airan ^a   Cai, Shixia ^a   Yang, Yi ^a   Lu, Xiaomin ^a   Qiu, Haibo ^a  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

Author keywords

Acute lung injury (ALI); Angiotensin converting enzyme 2 (ACE2); Gene therapy; Mesenchymal stem cells (MSCs)

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN[1-7]; ENDOTHELIAL NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; ANGIOTENSIN II; DIPEPTIDYL CARBOXYPEPTIDASE; INDUCIBLE NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL ULTRASTRUCTURE; CONTROLLED STUDY; ENZYME ACTIVITY; GENETIC TRANSDUCTION; LUNG INJURY; MALE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VASCULAR ENDOTHELIUM; ACUTE LUNG INJURY; ANIMAL; BLOOD; BONE MARROW CELL; C57BL MOUSE; CELL CULTURE; CYTOLOGY; DISEASE MODEL; ENZYMOLOGY; GENETICS; HEK293 CELL LINE; HUMAN; LUNG; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM; NEAR INFRARED SPECTROSCOPY; PATHOLOGY; PERMEABILITY; SPLEEN;

ACUTE LUNG INJURY; ANGIOTENSIN II; ANIMALS; BONE MARROW CELLS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; HEK293 CELLS; HUMANS; LIPOPOLYSACCHARIDES; LUNG; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; PEPTIDYL-DIPEPTIDASE A; PERMEABILITY; SPECTROSCOPY, NEAR-INFRARED; SPLEEN;

EID: 84940784911     PISSN: 09636897     EISSN: 15553892     Source Type: Journal    
DOI: 10.3727/096368914X685087     Document Type: Article

References (48)

1. Anjos-Afonso, F.; Siapati, E. K.; Bonnet, D. In vivo contribution of murine mesenchymal stem cells into multiple cell-types under minimal damage conditions. J. Cell Sci. 117(Pt 23):5655-5664; 2004.
2. Ashbaugh, D. G.; Bigelow, D. B.; Petty, T. L.; Levine, B. E. Acute respiratory distress in adults. Lancet 2(7511):319-323; 1967.
3. Baudin, B. New aspects on angiotensin-converting enzyme: From gene to disease. Clin. Chem. Lab. Med. 40(3):256-265; 2002.
4. Beckett, T.; Loi, R.; Prenovitz, R.; Poynter, M.; Goncz, K. K.; Suratt, B. T.; Weiss, D. J. Acute lung injury with endotoxin or NO2 does not enhance development of airway epithelium from bone marrow. Mol. Ther. 12(4):680-686; 2005.
5. Bhattacharya, J.; Matthay, M. A. Regulation and repair of the alveolar-capillary barrier in acute lung injury. Annu. Rev. Physiol. 75:593-615; 2013.
6. Cepkova, M.; Matthay, M. A. Pharmacotherapy of acute lung injury and the acute respiratory distress syndrome. J. Intensive Care Med. 21(3):119-143; 2006.
7. Clarke, N. E.; Turner, A. J. Angiotensin-converting enzyme 2: The first decade. Int. J. Hypertens. 2012:307-315; 2012.
8. Dong, L.; He, H. L.; Lu, X. M.; Yang, Y.; Qiu, H. B. Modulation of FLT3 signaling targets conventional dendritic cells to attenuate acute lung injury. APMIS 120(10):808-818; 2012.
9. Fang, W. F.; Cho, J. H.; He, Q.; Lin, M. C.; Wu, C. C.; Voelkel, N. F.; Douglas, I. S. Lipid A fraction of LPS induces a discrete MAPK activation in acute lung injury. Am. J. Physiol. Lung Cell Mol. Physiol. 293(2):L336-L344; 2007.
10. Gerlach, H.; Keh, D.; Semmerow, A.; Busch, T.; Lewandowski, K.; Pappert, D. M.; Rossaint, R.; Falke, K. J. Dose-response characteristics during long-term inhalation of nitric oxide in patients with severe acute respiratory distress syndrome: A prospective, randomized, controlled study. Am. J. Respir. Crit. Care Med. 167(7):1008-1015; 2003.
11. Gupta, N.; Su, X.; Popov, B.; Lee, J. W.; Serikov, V.; Matthay, M. A. Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J. Immunol. 179(3):1855-1863; 2007.
12. Hartley, J. L.; Temple, G. F.; Brasch, M. A. DNA cloning using in vitro site-specific recombination. Genome Res. 10(11):1788-1795; 2000.
13. Herzog, E. L.; Van Arnam, J.; Hu, B.; Krause, D. S. Threshold of lung injury required for the appearance of marrow-derived lung epithelia. Stem Cells 24(8):1986-1992; 2006.
14. Huang, X.; Sun, K.; Zhao, Y. D.; Vogel, S. M.; Song, Y.; Mahmud, N.; Zhao, Y. Y. Human CD34+ progenitor cells freshly isolated from umbilical cord blood attenuate inflammatory lung injury following LPS challenge. PLoS One 9(2):e88814; 2014.
15. Imai, Y.; Kuba, K.; Ohto-Nakanishi, T.; Penninger, J. M. Angiotensin-converting enzyme 2 (ACE2) in disease pathogenesis. Circ. J. 74(3):405-410; 2010.
16. Imai, Y.; Kuba, K.; Penninger, J. M. Angiotensin-converting enzyme 2 in acute respiratory distress syndrome. Cell. Mol. Life Sci. 64(15):2006-2012; 2007.
17. Imai, Y.; Kuba, K.; Rao, S.; Huan, Y.; Guo, F.; Guan, B.; Yang, P.; Sarao, R.; Wada, T.; Leong-Poi, H.; Crackower, M. A.; Fukamizu, A.; Hui, C. C.; Hein, L.; Uhlig, S.; Slutsky, A. S.; Jiang, C.; Penninger, J. M.. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 436(7047):112-116; 2005.
18. Laterre, P. F.; Wittebole, X.; Dhainaut, J. F. Anticoagulant therapy in acute lung injury. Crit. Care Med. 31(4 Suppl):S329-S336; 2003.
19. Le Blanc, K. Immunomodulatory effects of fetal and adult mesenchymal stem cells. Cytotherapy 5(6):485-489; 2003.
20. Le Blanc, K.; Tammik, C.; Rosendahl, K.; Zetterberg, E.; Ringden, O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp. Hematol. 31(10):890-896; 2003.
21. Lee, J. W.; Fang, X.; Gupta, N.; Serikov, V.; Matthay, M. A. Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proc. Natl. Acad. Sci. USA 106(38):16357-16362; 2009.
22. Li, H. D.; Zhang, Z. R.; Zhang, Q. X.; Qin, Z. C.; He, D. M.; Chen, J. S. Treatment with exogenous hydrogen sulfide attenuates hyperoxia-induced acute lung injury in mice. Eur. J. Appl. Physiol. 113(6):1555-1563; 2013.
23. Li, W.; Moore, M. J.; Vasilieva, N.; Sui, J.; Wong, S. K.; Berne, M. A.; Somasundaran, M.; Sullivan, J. L.; Luzuriaga, K.; Greenough, T. C.; Choe, H.; Farzan, M. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426(6965):450-454; 2003.
24. Li, X.; Molina-Molina, M.; Abdul-Hafez, A.; Ramirez, J.; Serrano-Mollar, A.; Xaubet, A.; Uhal, B. D. Extravascular sources of lung angiotensin peptide synthesis in idiopathic pulmonary fibrosis. Am. J. Physiol. Lung Cell Mol. Physiol. 291(5):L887-L895; 2006.
25. Liu, A. R.; Liu, L.; Chen, S.; Yang, Y.; Zhao, H. J.; Liu, L.; Guo, F. M.; Lu, X. M.; Qiu, H. B. Activation of canonical wnt pathway promotes differentiation of mouse bone marrow-derived MSCs into type II alveolar epithelial cells, confers resistance to oxidative stress, and promotes their migration to injured lung tissue in vitro. J. Cell. Physiol. 228(6):1270-1283; 2013.
26. Liu, J.; Zhang, P. S.; Yu, Q.; Liu, L.; Yang, Y.; Guo, F. M.; Qiu, H. B. Losartan inhibits conventional dendritic cell maturation and Th1 and Th17 polarization responses: Novel mechanisms of preventive effects on lipopolysaccharide-induced acute lung injury. Int. J. Mol. Med. 29(2):269-276; 2012.
27. Liu, L.; Qiu, H. B.; Yang, Y.; Wang, L.; Ding, H. M.; Li, H. P. Losartan, an antagonist of AT1 receptor for angiotensin II, attenuates lipopolysaccharide-induced acute lung injury in rat. Arch. Biochem. Biophys. 481(1):131-136; 2009.
28. Liu, Z.; Liu, S.; Niu, G.; Wang, F.; Liu, S.; Chen, X. Optical imaging of integrin alphavbeta3 expression with near-infrared fluorescent RGD dimer with tetra(ethylene glycol) linkers. Mol. Imaging 9(1):21-29; 2010.
29. Mei, S. H.; McCarter, S. D.; Deng, Y.; Parker, C. H.; Liles, W. C.; Stewart, D. J. Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1. PLoS Med. 4(9):e269; 2007.
30. Molthen, R. C.; Wu, Q.; Fish, B. L.; Moulder, J. E.; Jacobs, E. R.; Medhora, M. M. Mitigation of radiation induced pulmonary vascular injury by delayed treatment with capto-pril. Respirology 17(8):1261-1268; 2012.
31. Osterreicher, C. H.; Taura, K.; De Minicis, S.; Seki, E.; Penz-Osterreicher, M.; Kodama, Y.; Kluwe, J.; Schuster, M.; Oudit, G. Y.; Penninger, J. M.; Brenner, D. A. Angiotensin-converting-enzyme 2 inhibits liver fibrosis in mice. Hepatology 50(3):929-938; 2009.
32. Rey-Parra, G. J.; Vadivel, A.; Coltan, L.; Hall, A.; Eaton, F.; Schuster, M.; Loibner, H.; Penninger, J. M.; Kassiri, Z.; Oudit, G. Y.; Thebaud, B. Angiotensin converting enzyme 2 abrogates bleomycin-induced lung injury. J. Mol. Med. 90(6):637-647; 2012.
33. Rojas, M.; Xu, J.; Woods, C. R.; Mora, A. L.; Spears, W.; Roman, J.; Brigham, K. L. Bone marrow-derived mes-enchymal stem cells in repair of the injured lung. Am. J. Respir. Cell Mol. Biol. 33(2):145-152; 2005.
34. Schaller, M. D.; Waeber, B.; Nussberger, J.; Brunner, H. R. Angiotensin II, vasopressin, and sympathetic activity in conscious rats with endotoxemia. Am. J. Physiol. 249(6 Pt 2):H1086-H1092; 1985.
35. Sprung, C. L.; Caralis, P. V.; Marcial, E. H.; Pierce, M.; Gelbard, M. A.; Long, W. M.; Duncan, R. C.; Tendler, M. D.; Karpf, M. The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study. N. Engl. J. Med. 311(18):1137-1143; 1984.
36. Treacy, O.; Ryan, A. E.; Heinzl, T.; O'Flynn, L.; Cregg, M.; Wilk, M.; Odoardi, F.; Lohan, P.; O'Brien, T.; Nosov, M.; Ritter, T. Adenoviral transduction of mesenchymal stem cells: In vitro responses and in vivo immune responses after cell transplantation. PLoS One 7(8):e42662; 2012.
37. Treml, B.; Neu, N.; Kleinsasser, A.; Gritsch, C.; Finsterwalder, T.; Geiger, R.; Schuster, M.; Janzek, E.; Loibner, H.; Penninger, J.; Loeckinger, A. Recombinant angiotensin-converting enzyme 2 improves pulmonary blood flow and oxygenation in lipopolysaccharide-induced lung injury in piglets. Crit. Care Med. 38(2):596-601; 2010.
38. Wang, X. Y.; Ju, S.; Li, C.; Peng, X. G.; Chen, A. F.; Mao, H.; Teng, G. J. Non-invasive imaging of endothelial progenitor cells in tumor neovascularization using a novel dual-modality paramagnetic/near-infrared fluorescence probe. PLoS One 7(11):e50575; 2012.
39. Wang, Y. Y.; Li, X. Z.; Wang, L. B. Therapeutic implications of mesenchymal stem cells in acute lung injury/ acute respiratory distress syndrome. Stem Cell Res. Ther. 4(3):45; 2013.
40. Ware, L. B.; Matthay, M. A. The acute respiratory distress syndrome. N. Engl. J. Med. 342(18):1334-1349; 2000.
41. Wosten-van Asperen, R. M.; Lutter, R.; Specht, P. A.; Moll, G. N.; van Woensel, J. B.; van der Loos, C. M.; van Goor, H.; Kamilic, J.; Florquin, S.; Bos, A. P. Acute respiratory distress syndrome leads to reduced ratio of ACE/ACE2 activities and is prevented by angiotensin-(1-7) or an angiotensin II receptor antagonist. J. Pathol. 225(4):618-627; 2011.
42. Xu, J.; Woods, C. R.; Mora, A. L.; Joodi, R.; Brigham, K. L.; Iyer, S.; Rojas, M. Prevention of endotoxin-induced systemic response by bone marrow-derived mesenchymal stem cells in mice. Am. J. Physiol. Lung Cell Mol. Physiol. 293(1):L131-L141; 2007.
43. Yamada, M.; Kubo, H.; Kobayashi, S.; Ishizawa, K.; Numasaki, M.; Ueda, S.; Suzuki, T.; Sasaki, H. Bone marrow-derived progenitor cells are important for lung repair after lipopolysaccharide-induced lung injury. J. Immunol. 172(2):1266-1272; 2004.
44. Ye, M.; Wysocki, J.; Gonzalez-Pacheco, F. R.; Salem, M.; Evora, K.; Garcia-Halpin, L.; Poglitsch, M.; Schuster, M.; Batlle, D. Murine recombinant angiotensin-converting enzyme 2: Effect on angiotensin II-dependent hypertension and distinctive angiotensin-converting enzyme 2 inhibitor characteristics on rodent and human angiotensin-converting enzyme 2. Hypertension 60(3):730-740; 2012.
45. Zhang, H.; Sun, G. Y. LPS induces permeability injury in lung microvascular endothelium via AT(1) receptor. Arch. Biochem. Biophys. 441(1):75-83; 2005.
46. Zhao, Y. D.; Huang, X.; Yi, F.; Dai, Z.; Qian, Z.; Tiruppathi, C.; Tran, K.; Zhao, Y. Y. Endothelial FoxM1 mediates bone marrow progenitor cell-induced vascular repair and resolution of inflammation following inflammatory lung injury. Stem Cells 32(7):1855-1864; 2014.
47. Zhao, Y. D.; Ohkawara, H.; Vogel, S. M.; Malik, A. B.; Zhao, Y. Y. Bone marrow-derived progenitor cells prevent thrombin-induced increase in lung vascular permeability. Am. J. Physiol. Lung Cell Mol. Physiol. 298(1):L36-L44; 2010.
48. Zhu, Y.; Qiu, H. B.; Yang, Y.; Liu, L.; Zhao, M. M.; Chen, Q. H.; Guo, T. Angiotensin II type 2 receptor expression and its modulation in angiotensin II induced acute lung injury in rat. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 20(10):585-587; 2008.